The 2026 Nobel Prize in Chemistry went to Henri Kagan and Kenso Soai. They showed how a chemical reaction that starts almost fifty-fifty ends with one mirror image only. I explain their work in plain words, with spearmint, a drawer of gloves and the thalidomide scandal. Then I apply the same test to corporate sustainability across People, Planet and Profit, from a herbicide that cut its dose by up to 40% to CSRD reports that count tonnes and euros but say little about how the

The 2026 Nobel Prize in Medicine went to Karl Deisseroth, Peter Hegemann and Georg Nagel for optogenetics, a light switch that turns chosen brain cells on and off. I explain the science in plain words, with a green alga that swims toward light and a blind patient who regained partial sight. Then I hold it next to corporate sustainability. Most CSR reports measure activity the way neuroscience did before 2005. They record correlations and never test causes, across People, Plan

Pink October has pushed breast cancer screening since 1985, yet new cases still rise in half the countries studied by IARC in 2025. This ESG Audit runs the pink ribbon through E, S and G: the endocrine disruptors missing from prevention advice, safety limits built around the male body, and the board accountability gap before the EU CLP deadline of 1 November 2026. It ends with the business model that makes a company pay for what goes into its product.

Ownership looks like the win. Buy the machine. Own the asset. Put in the balance sheet and call it a strategy. I have sat across the table from boards that repeat this logic for twenty years, and I have watched what that logic cost them five years later. The buyer owns the failure. The buyers owns the waste. the buyer owns the disposal cost nobody put in the brochure. Ownership was never the prize. It is the risk, quietly handed to whoever signed the check. A different model

Brussels deregulated gene-edited crops on 17 June 2026, citing climate adaptation, food security, and EU competitiveness. NGT-1 crops under 20 genetic modifications now skip risk assessment and traceability. But while labeling rules were dropped, patent rights for Bayer, Syngenta, and Corteva stayed untouched. This piece breaks down the real governance failure behind the CRISPR crop vote.

Corporate Social Responsibility (CSR) is no longer a side note in business. It’s a critical driver of success. But how do you create CSR strategies that truly make an impact online? How do you ensure your efforts resonate, engage, and deliver measurable results? The answer lies in mastering the art of online CSR strategies that are bold, authentic, and actionable. You might be wondering: Isn’t CSR just about doing good? Yes, but it’s also about doing well by doing good. It’s

Every ESG framework measures board composition and audit independence. Almost none ask the question that determines whether governance actually works: who decides which harms are worth measuring? That is not abstract. It has a documented history. In CSR, we call it materiality assessment. The mechanism sounds technical. It is not. It is a values decision dressed in accounting language. And when you trace it back through history, the pattern is impossible to ignore.

Forty years after Chernobyl, physical chemist and EU climate policy expert Dr. Audrey-Flore Ngomsik identifies the same governance failure in AI: unpriced environmental liability, silenced technical experts, and boards approving decisions they cannot evaluate. Three ESG pillars. All sources linked. August 2, 2026 deadline.

How Dr. Audrey-Flore Ngomsik is proving that sustainability can be profitable.

International Women’s Day focus: The patient was never me. But it might be you pubished in the Bulletin.be on March 8th, 2026

We spent two years as an external consultant watching companies hire managers and directors. They paid us to improve their processes. What we saw was a masterclass in how bias disguises itself as professional judgment. Same credentials on paper. Wildly different outcomes in practice. Here’s what nobody wants to admit.

Titanium dioxide nanoparticles found illegally in Sephora, Nocibé, René Furterer cosmetics. AVICENN investigation confirms EU Regulation 2022/1176 violations three years post-ban. French Health Ministry escalates to ANSES. Reformulation costs €200K minimum per product line. What's your company's regulatory exposure?